Episurf Medical AB (publ) (EPIS-B.ST)
SEK 0.13
(-2.03%)
SEK 0.13
(-2.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -84.8 Million | -69.5 Million | -59.7 Million | -54.1 Million | -59.2 Million | -52.3 Million |
| Net Income | -94.8 Million | -77 Million | -69.4 Million | -63.4 Million | -68.9 Million | -57.5 Million |
| Depreciation & Amortization | 6 Million | 7.4 Million | 7.4 Million | 7.6 Million | 7.4 Million | 4.8 Million |
| Deferred income taxes | -11.9 Million | - | - | - | - | - |
| Stock-based compensation | 700 Thousand | -200 Thousand | 3.3 Million | 1.4 Million | 100 Thousand | 200 Thousand |
| Change in working capital | 800 Thousand | 900 Thousand | -900 Thousand | 200 Thousand | 2.6 Million | -100 Thousand |
| Other non-cash items | 14.4 Million | -600 Thousand | -100 Thousand | 100 Thousand | -400 Thousand | 300 Thousand |
| Investing Cash Flow | -9.5 Million | -11.2 Million | -6.5 Million | -5.1 Million | -5.5 Million | -9.7 Million |
| Investments in PPE | -9.5 Million | -11.3 Million | -7 Million | -4.6 Million | -5.5 Million | -9.7 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -500 Thousand | - | - |
| Sales/Maturities of investments | - | - | 500 Thousand | - | - | - |
| Other Investing Activities | -9.5 Million | 100 Thousand | -6.4 Million | -5.1 Million | -5.5 Million | -9.7 Million |
| Financing Cash Flow | -3 Million | -1.9 Million | 149.2 Million | 188.8 Million | 61.6 Million | 19.1 Million |
| Debt repayment | -3.2 Million | -2.4 Million | -2.4 Million | -2.2 Million | -2 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 200 Thousand | 500 Thousand | 151.6 Million | 191 Million | 63.6 Million | 12.4 Million |
| Other Financing Activities | -3.2 Million | -1.9 Million | 149.2 Million | 188.8 Million | 61.6 Million | 6.7 Million |
| Accounts receivables | 400 Thousand | 1.2 Million | -1.7 Million | -600 Thousand | -400 Thousand | 1 Million |
| Accounts payables | 2.2 Million | -400 Thousand | 800 Thousand | 1 Million | 3.3 Million | -1.3 Million |
| Inventory | -1.8 Million | 100 Thousand | -200 Thousand | -200 Thousand | -300 Thousand | 200 Thousand |
| Other working capital | 2.2 Million | 1.1 Million | 200 Thousand | 200 Thousand | 2.8 Million | -300 Thousand |
| Cash at beginning of period | 155.3 Million | 237.9 Million | 155 Million | 25.3 Million | 28.3 Million | 71.3 Million |
| Cash at end of period | 57.9 Million | 155.3 Million | 237.9 Million | 155 Million | 25.3 Million | 28.3 Million |
| Capital Expenditure | -9.5 Million | -11.3 Million | -7 Million | -4.6 Million | -5.5 Million | -9.7 Million |
| Effect of forex changes on cash | -100 Thousand | - | -100 Thousand | 100 Thousand | 100 Thousand | -100 Thousand |
| Net cash flow / Change in cash | -97.4 Million | -82.6 Million | 82.9 Million | 129.7 Million | -3 Million | -43 Million |
| Free Cash Flow | -94.3 Million | -80.8 Million | -66.7 Million | -58.7 Million | -64.7 Million | -62 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.3 Million | -21.4 Million | -20.5 Million | -21.9 Million | -94.8 Million | -20.5 Million |
| Depreciation & Amortization | 2.3 Million | 2.1 Million | 2.1 Million | 2.3 Million | 6 Million | 3.2 Million |
| Deferred income taxes | - | - | - | -5.7 Million | -11.9 Million | - |
| Stock-based compensation | 200 Thousand | 200 Thousand | 400 Thousand | 200 Thousand | 700 Thousand | 400 Thousand |
| Change in working capital | -3.9 Million | 100 Thousand | -4.3 Million | -900 Thousand | 800 Thousand | -5.7 Million |
| Other non-cash items | 400 Thousand | 4.6 Million | 8.9 Million | 5.6 Million | 14.4 Million | 100 Thousand |
| Investing Cash Flow | -1.6 Million | -2.5 Million | -900 Thousand | -1.5 Million | -9.5 Million | -3 Million |
| Investments in PPE | -1.6 Million | -2.5 Million | -900 Thousand | -1.5 Million | -9.5 Million | -3 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.6 Million | -2.5 Million | -900 Thousand | -1.5 Million | -9.5 Million | -3 Million |
| Financing Cash Flow | -1.1 Million | 73.5 Million | -100 Thousand | -800 Thousand | -3 Million | -800 Thousand |
| Debt repayment | - | -800 Thousand | -100 Thousand | - | -3.2 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -300 Thousand | - | - | - | - | - |
| Common Stock Issuance | -300 Thousand | 74.3 Million | - | 2.6 Million | 200 Thousand | -800 Thousand |
| Other Financing Activities | -800 Thousand | 100 Thousand | - | -3.4 Million | -3.2 Million | -800 Thousand |
| Accounts receivables | -400 Thousand | 800 Thousand | -2.4 Million | 1.6 Million | 400 Thousand | -1.2 Million |
| Accounts payables | -3.2 Million | -1 Million | -2.2 Million | -1.3 Million | 2.2 Million | -4.7 Million |
| Inventory | -200 Thousand | 200 Thousand | 300 Thousand | -1.2 Million | -1.8 Million | 100 Thousand |
| Other working capital | -3.3 Million | 100 Thousand | -4 Million | -100 Thousand | 2.2 Million | 100 Thousand |
| Cash at beginning of period | 86.7 Million | 34.6 Million | 57.9 Million | 80.7 Million | 155.3 Million | 107 Million |
| Cash at end of period | 66.8 Million | 86.7 Million | 34.6 Million | 57.9 Million | 57.9 Million | 80.7 Million |
| Capital Expenditure | -1.6 Million | -2.5 Million | -900 Thousand | -1.5 Million | -9.5 Million | -3 Million |
| Effect of forex changes on cash | - | - | - | -100 Thousand | -100 Thousand | - |
| Net cash flow / Change in cash | -19.9 Million | 52.1 Million | -23.3 Million | -22.8 Million | -97.4 Million | -26.3 Million |
| Free Cash Flow | -18.9 Million | -21.4 Million | -23.2 Million | -21.9 Million | -94.3 Million | -25.5 Million |
STAA
EMIL
ECH
2869
MLRT
OCTO